What is Frovatriptan Succinate
Approved as Treatment by the FDA
Frovatriptan, commonly known as Frova, is approved by the FDA for 2 uses like Migraine With Aura and Migraine Without Aura .Effectiveness
When to interrupt dosage
The portion of Frovatriptan Succinate is contingent upon the diagnosed state, including Menstruation, Migraine Without Aura and Migraine With Aura. The quantity of dosage is contingent upon the approach of administration (e.g. Tablet or Tablet, film coated) noted in the table beneath.Warnings
Frovatriptan Succinate ContraindicationsFrovatriptan Succinate Novel Uses: Which Conditions Have a Clinical Trial Featuring Frovatriptan Succinate?
4 active studies are presently assessing the potential of Frovatriptan Succinate in alleviating symptoms of Migraine Without Aura, Migraine With Aura and Menstrual Migraines.Frovatriptan Succinate Reviews: What are patients saying about Frovatriptan Succinate?
Patient Q&A Section about frovatriptan succinate
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is a common side effects of frovatriptan?
"The side effects of the drug include dizziness, headache, dry mouth, indigestion, drowsiness, excessive tiredness, flushing, hot or cold feeling."
How long does it take for frovatriptan to work?
"Although frovatriptan has the lowest efficacy of the triptans in terms of 2-hour response and 2-hour pain free, 25% of patients who take it experience headache relief within 1.3 to 1.7 hours."
What is frovatriptan succinate used for?
"Frovatriptan is used to treat acute migraine headaches in adults. Frovatriptan works by agonizing serotonin 5-HT1B/1D receptors, which are found on the blood vessels and nerve endings in the brain. This causes the blood vessels to constrict and blocks the release of pain-causing chemicals from the nerve endings. Many people find that their headaches go away completely after they take frovatriptan."
Is frovatriptan better than sumatriptan?
"A large RCT comparing sumatriptan 100 mg to frovatriptan 2.5 mg found that the headache relief rates were 47% and 37% respectively, with similar recurrence rates for both drugs."